News
![Cerevel Parkinson’s data adds lustre to AbbVie acquisition](/sites/default/files/styles/x_large/public/2024-04/Parkinsons.jpg?itok=QziGIWV8)
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, wh